Evidence mapPaperPMID 41656244Full record

ReviewJournal of translational medicine2026

Multiomics: the intersection of personalized nutrition in cardiometabolic diseases.

Elif Çelik, Emine Kocyigit, Feray Gençer Bingöl, Cansu Karaçolak, Özge Cemali, Martina Simonelli, Duygu Ağagündüz, Raffaele Capasso

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elif ÇelikDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Süleyman Demirel University, Isparta, 32260, Türkiye.
Emine KocyigitDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Ordu University, Ordu, 52200, Türkiye.
Feray Gençer BingölDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Burdur Mehmet Akif Ersoy University, Burdur, 15100, Türkiye.
Cansu KaraçolakDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Burdur Mehmet Akif Ersoy University, Burdur, 15100, Türkiye.
Özge CemaliDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Trakya University, Edirne, 22030, Türkiye.
Martina SimonelliDepartment of Parmacy, University of Naples Federico II, 80131, Naples, Italy.
Duygu AğagündüzDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Emek, Ankara, 06490, Türkiye. duyguturkozu@gazi.edu.tr.
Raffaele CapassoDepartment of Agricultural Sciences, University of Naples Federico II, 80055, Portici, (Naples), Italy. rafcapas@unina.it.ORCID http://orcid.org/0000-0002-3335-1822

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiometabolic diseases are among the leading causes of increasing morbidity and mortality worldwide. However, current population-based dietary recommendations do not sufficiently account for biological differences between individuals and therefore do not have the same effect on everyone. The multiomic approach, which incorporates genomic, epigenomic, transcriptomic, proteomic, metabolomic, and microbiome data, facilitates more accurate classification of disease risk and selection of appropriate nutritional interventions by mapping food-disease relationships across different biological layers.

methodsThrough a narrative synthesis of the current literature, we focused on evidence from multiomic studies to assess their ability to guide personalized nutrition strategies based on individual genetic, metabolic, and microbiome characteristics in cardiometabolic diseases.

resultsRecent evidence indicates that metabolomic markers have been reported to provide predictive value in addition to classic risk indicators and to increase the predictive power of models when combined with genetic data. Microbiome research shows that glycemic and lipemic responses can be predicted using algorithms based on gut microbiota. Recent clinical studies show that personalized nutrition plans, which evaluate the microbiome and clinical characteristics together, improve continuous glucose monitoring-based glycemic control, glycated hemoglobin levels, and triglycerides more than the classic Mediterranean diet.

conclusionThis review summarizes the current multiomic evidence, discusses the methodological and practical challenges in this field, and highlights future priorities. The integration of digital biomarkers obtained from wearable technologies with multiomic systems and artificial intelligence-supported models, when developed in accordance with ethical and equitable access principles, has the potential to support the transition from the discovery phase to patient-centered clinical applications.

Indexed as

Cardiovascular DiseasesMetabolic DiseasesMultiomicsPrecision MedicineBiomarkersHumansBiomarkersCardiometabolic diseaseMultiomicsObesityPersonalized nutritionType 2 diabetes

Identifiers

PMID41656244
PMCPMC12983658

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.